Golden Helix, Inc.

Automated and Guided Workflows for Clinical Testing Using NGS Assays

Integrating CNV analysis into a NextGen sequencing clinical analytics platform

Clinical Interpretation of Variants Based on ACMG Guidelines

Today, Golden Helix, Inc. announced a multi-year partnership with Sentieon, a company that develops bioinformatics secondary analysis tools to process genomic data.

Today, Golden Helix, Inc. announced the introduction of VS-CNV for Gene Panels and Exomes. The company has developed this capability in partnership with PreventionGenetics.

Golden Helix, Inc. recently announced the availability of Copy Number Variation (CNV) analysis in its VarSeq software. The CNV capability is part of the VarSeq clinical reports package.

Today, Golden Helix announced the upcoming release of VSWarehouse, the company’s newest software solution for genetic data warehousing.

Golden Helix makes it to Pharma Tech Outlook’s Top 10 Analytics Solution Providers list for its expertise in empowering biologists to perform complex analysis.

Today, Golden Helix, Inc. announces their collaboration with Fulgent Diagnostics as they prepare to integrate VSPipeline into their current bioinformatics pipeline.

Today, Golden Helix, Inc. announced the addition of VSPipeline to its VarSeq software.